Dai and colleagues conducted several in vitro and in vivo experiments, demonstrating that CCA cells treated with unconjugated BAs—namely, CA, DCA, and CDCA—enhanced the expression of FXR, while conjugated BAs decreased its expression. Here, NR1H4 is linked to cholangiocarcinoma.